Reports for TEVA CANADA LIMITED
Company Name
TEVA CANADA LIMITED
Totals |
||
Shortage reports |
2645 |
|
| Actual shortage: | 257 (10%) | |
| Anticipated shortage: | 0 (0%) | |
| Avoided shortage: | 9 (0%) | |
| Resolved: | 2379 (90%) | |
Discontinuation Reports |
250 |
|
| To be discontinued: | 3 (1%) | |
| Discontinued: | 247 (99%) | |
| Reversed: | 0 (0%) | |
Late reports |
329 (11%) |
|
Overdue reports |
29 (11%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-BETAHISTINE | 24MG | TABLET | Resolved | 2020-09-03 | 2020-10-15 | 123723 |
| TEVA-BETAHISTINE | 24MG | TABLET | Resolved | 2023-02-09 | 2023-07-06 | 184201 |
| TEVA-BETAHISTINE | 24MG | TABLET | Resolved | 2023-06-19 | 2023-06-21 | 195512 |
| TEVA-BETAHISTINE | 24MG | TABLET | Resolved | 2023-10-26 | 2023-11-03 | 208257 |
| TEVA-BETAHISTINE | 24MG | TABLET | Actual shortage | 2024-02-01 | 2024-04-11 | 218129 |
| TEVA-TELMISARTAN HCTZ | 25.0MG 80.0MG | TABLET | Resolved | 2018-11-20 | 2019-03-12 | 67243 |
| TEVA-TELMISARTAN HCTZ | 25.0MG 80.0MG | TABLET | Resolved | 2018-11-20 | 2019-03-12 | 67246 |
| TEVA-TELMISARTAN HCTZ | 25.0MG 80.0MG | TABLET | Resolved | 2021-06-24 | 2022-01-20 | 141489 |
| TEVA-TELMISARTAN HCTZ | 25.0MG 80.0MG | TABLET | Actual shortage | 2024-04-11 | 2024-04-11 | 224901 |
| TEVA-CHLORPROMAZINE | 25.0MG | TABLET | Resolved | 2017-04-25 | 2017-09-19 | 8065 |
| TEVA-CHLORPROMAZINE | 25.0MG | TABLET | Resolved | 2023-04-27 | 2023-06-09 | 190761 |
| RATIO-IPRATROPIUM UDV | 250MCG | SOLUTION | Resolved | 2017-05-23 | 2017-09-19 | 10892 |
| TEVA-IPRATROPIUM STERINEBS | 250MCG | SOLUTION | Resolved | 2020-05-01 | 2020-05-14 | 113764 |
| TEVA-IPRATROPIUM STERINEBS | 250MCG | SOLUTION | Resolved | 2022-01-20 | 2022-04-21 | 153165 |
| TEVA-IPRATROPIUM STERINEBS | 250MCG | SOLUTION | Resolved | 2022-02-10 | 2022-07-01 | 154720 |
| TEVA-IPRATROPIUM STERINEBS | 250MCG | SOLUTION | Resolved | 2022-04-28 | 2022-07-01 | 159590 |
| TEVA-TERIPARATIDE INJECTION | 250MCG | SOLUTION | Resolved | 2022-10-28 | 2022-12-15 | 173004 |
| TEVA-IPRATROPIUM STERINEBS | 250MCG | SOLUTION | Resolved | 2023-04-27 | 2023-06-27 | 190674 |
| TEVA-IPRATROPIUM STERINEBS | 250MCG | SOLUTION | Resolved | 2023-06-19 | 2023-06-27 | 195618 |
| TEVA-IPRATROPIUM STERINEBS | 250MCG | SOLUTION | Actual shortage | 2023-07-11 | 2023-12-07 | 198292 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| DOCETAXEL INJECTION | Discontinued | 2018-10-12 | 2018-10-12 | 63937 | ||
| DOCETAXEL INJECTION | Discontinued | 2018-10-12 | 2018-10-12 | 63940 | ||
| TEVA-CIPROFLOXACIN | Discontinued | 2018-10-12 | 2018-10-12 | 63952 | ||
| GEMCITABINE FOR INJECTION | Discontinued | 2018-10-12 | 2018-10-12 | 63967 | ||
| GEMCITABINE FOR INJECTION | Discontinued | 2018-10-12 | 2018-10-12 | 63970 | ||
| ACT ESCITALOPRAM | Discontinued | 2018-10-17 | 2018-10-17 | 64520 | ||
| ACT ESCITALOPRAM | Discontinued | 2018-10-17 | 2018-10-17 | 64526 | ||
| ACT ESCITALOPRAM | Discontinued | 2018-10-17 | 2018-10-17 | 64529 | ||
| ACT ESCITALOPRAM | Discontinued | 2018-10-17 | 2018-10-17 | 64532 | ||
| ACT ESCITALOPRAM | Discontinued | 2018-10-17 | 2018-10-17 | 64535 | ||
| TEVA-CIPROFLOXACIN | Discontinued | 2018-10-17 | 2018-10-17 | 64544 | ||
| TEVA-CIPROFLOXACIN | Discontinued | 2018-10-17 | 2018-10-17 | 64547 | ||
| TEVA-CIPROFLOXACIN | Discontinued | 2018-10-17 | 2018-10-17 | 64550 | ||
| TEVA-CIPROFLOXACIN | Discontinued | 2018-10-17 | 2018-10-17 | 64553 | ||
| RATIO-ATORVASTATIN | Discontinued | 2018-10-17 | 2018-10-17 | 64589 | ||
| RATIO-ATORVASTATIN | Discontinued | 2018-10-17 | 2018-10-17 | 64592 | ||
| RATIO-MEMANTINE | Discontinued | 2018-10-17 | 2018-10-17 | 64595 | ||
| RATIO-MEMANTINE | Discontinued | 2018-10-17 | 2018-10-17 | 64598 | ||
| RATIO-ATORVASTATIN | Discontinued | 2018-10-17 | 2018-10-17 | 64615 | ||
| RATIO-ATORVASTATIN | Discontinued | 2018-10-17 | 2018-10-17 | 64623 |